UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From opt-out to opt-in consent for secondary use of medical data and residual biomaterial: An evaluation using the RE-AIM framework

PloS one, 2024-03, Vol.19 (3), p.e0299430-e0299430

2024

Volltextzugriff (PDF)

Expanding the boundaries of previously obtained informed consent in research: Views from participants in the Personalised Risk‐based Mammascreening study

Health expectations : an international journal of public participation in health care and health policy, 2023-06, Vol.26 (3), p.1308-1317

2023

Volltextzugriff (PDF)

The Radboud Biobank: A Central Facility for Disease-Based Biobanks to Optimise Use and Distribution of Biomaterial for Scientific Research in the Radboud University Medical Center, Nijmegen

Open journal of bioresources, 2020, Vol.5, p.2

2020

Volltextzugriff (PDF)

Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients

Clinical chemistry (Baltimore, Md.), 2004-11, Vol.50 (11), p.1986-1993

2004

Volltextzugriff (PDF)

Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer

Oncogene, 2002-12, Vol.21 (55), p.8506-8509

2002

Volltextzugriff (PDF)

Parelsnoer Institute Biobank Hereditary Colorectal Cancer: A Joint Infrastructure for Patient Data and Biomaterial on Hereditary Colorectal Cancer in the Netherlands

Open journal of bioresources, 2019-04, Vol.6

2019

Volltextzugriff (PDF)

Mammaglobin Is Associated With Low-Grade, Steroid Receptor-Positive Breast Tumors From Postmenopausal Patients, and Has Independent Prognostic Value for Relapse-Free Survival Time

Journal of clinical oncology, 2004-02, Vol.22 (4), p.691-698

2004

Volltextzugriff (PDF)

Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1

Gastroenterology (New York, N.Y. 1943), 2015-10, Vol.149 (4), p.897-906.e19

2015

Volltextzugriff (PDF)

Recommendations for a Dutch Sustainable Biobanking Environment

Biopreservation and biobanking, 2021-06, Vol.19 (3), p.228-240

2021

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Independently Predicts the Efficacy of Postoperative Radiotherapy in Node-Negative Breast Cancer Patients

Clinical cancer research, 2003-12, Vol.9 (17), p.6363-6370

2003

Volltextzugriff (PDF)

Protocol of the Healthy Brain Study: An accessible resource for understanding the human brain and how it dynamically and individually operates in its bio-social context

PloS one, 2021-12, Vol.16 (12), p.e0260952-e0260952

2021

Volltextzugriff (PDF)

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

American journal of human genetics, 2008-04, Vol.82 (4), p.937-948

2008

Volltextzugriff (PDF)

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

BMJ (Online), 2012-09, Vol.345 (sep06 2), p.e5660-e5660

2012

Volltextzugriff (PDF)

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer

Thrombosis and haemostasis, 2004-03, Vol.91 (3), p.514-521

2004

Volltextzugriff (PDF)

Patients to learn from: on the need for systematic integration of research and care in academic health care

Journal of clinical and translational research, 2018-12, Vol.3 (Suppl 3), p.401-406

2018

Volltextzugriff (PDF)

Patients to learn from: on the need for systematic integration of research and care in academic health care

Journal of clinical and translational research, 2018-12, Vol.3 (Suppl 3), p.401-406

2018

Volltextzugriff (PDF)

Body weight and risk of breast cancer in BRCA1/2 mutation carriers

Breast cancer research and treatment, 2011-02, Vol.126 (1), p.193-202

2011

Volltextzugriff (PDF)

Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

Breast cancer research and treatment, 2010-02, Vol.120 (1), p.235-244

2010

Volltextzugriff (PDF)

International biobanks: do or do not?

Future science OA, 2015-11, Vol.1 (4), p.FSO75-FSO75

2015

Volltextzugriff (PDF)

Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk

International journal of cancer, 2013-07, Vol.133 (1), p.156-163

2013

Volltextzugriff (PDF)

Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers

Journal of clinical epidemiology, 2011-12, Vol.64 (12), p.1434-1443

2011

Volltextzugriff (PDF)

A Stepwise Procedure to Define a Data Collection Framework for a Clinical Biobank

Biopreservation and biobanking, 2018-04, Vol.16 (2), p.138-147

2018

Volltextzugriff (PDF)

Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: A prognostic marker for good clinical outcome in human breast carcinoma

Cancer, 2003-06, Vol.97 (11), p.2710-2715

2003

Volltextzugriff (PDF)

Correction: Protocol of the Healthy Brain Study: An accessible resource for understanding the human brain and how it dynamically and individually operates in its bio-social context

PloS one, 2022-01, Vol.17 (4), p.e0267071

2022

Volltextzugriff (PDF)

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RSK)

BMJ. British medical journal (International ed.), 2012-10, Vol.345 (7878), p.14

International edition, 2012

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

From opt-out to opt-in consent for secondary use of medical data and residual biomaterial: An evaluation using the RE-AIM framework

Expanding the boundaries of previously obtained informed consent in research: Views from participants in the Personalised Risk‐based Mammascreening study

The Radboud Biobank: A Central Facility for Disease-Based Biobanks to Optimise Use and Distribution of Biomaterial for Scientific Research in the Radboud University Medical Center, Nijmegen

Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients

Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer

Parelsnoer Institute Biobank Hereditary Colorectal Cancer: A Joint Infrastructure for Patient Data and Biomaterial on Hereditary Colorectal Cancer in the Netherlands

Mammaglobin Is Associated With Low-Grade, Steroid Receptor-Positive Breast Tumors From Postmenopausal Patients, and Has Independent Prognostic Value for Relapse-Free Survival Time

Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1

Recommendations for a Dutch Sustainable Biobanking Environment

Vascular Endothelial Growth Factor Independently Predicts the Efficacy of Postoperative Radiotherapy in Node-Negative Breast Cancer Patients

Protocol of the Healthy Brain Study: An accessible resource for understanding the human brain and how it dynamically and individually operates in its bio-social context

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer

Patients to learn from: on the need for systematic integration of research and care in academic health care

Patients to learn from: on the need for systematic integration of research and care in academic health care

Body weight and risk of breast cancer in BRCA1/2 mutation carriers

Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

International biobanks: do or do not?

Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk

Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers

A Stepwise Procedure to Define a Data Collection Framework for a Clinical Biobank

Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: A prognostic marker for good clinical outcome in human breast carcinoma

Correction: Protocol of the Healthy Brain Study: An accessible resource for understanding the human brain and how it dynamically and individually operates in its bio-social context

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RSK)

Suchergebnisse filtern